Latest Regulatory Approval News

Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.

ReNerve Limited has gained marketing approval for its NervAlign® Nerve Cuff™ in Bahrain, marking its first regulatory success in the Middle East and opening access to a rapidly expanding regional market.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

Copper Search Ltd has successfully raised $850,000 through a placement and announced a subsequent $504,364 rights issue to fund exploration targeting Heavy Mineral Sands in South Australia and gold-copper prospects in New South Wales.

NexGen Energy has reported its highest-grade uranium assay results to date from the Patterson Corridor East, highlighting exceptional mineralization that could reshape the company’s exploration outlook.

New Frontier Minerals accelerates its NWQ Copper Project development by sending bulk samples to Austral Resources’ Mt Kelly plant, formalizing a key processing partnership that could fast-track copper output.

Xanadu Mines Limited has received a conditional off-market takeover offer from Bastion Mining Pte Ltd at A$0.08 per share, representing a significant premium. The company’s independent Takeover Committee unanimously recommends acceptance, supported by an independent expert’s fair and reasonable valuation.

MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.

Beacon Minerals has secured an option agreement to acquire the Wealth of Nations gold tenements near its Jaurdi processing plant, setting the stage for renewed exploration and potential resource growth.

M3 Mining Limited has abandoned its energy sector acquisition plans, selling its M3 Energy subsidiary to Jerboa Energy Ltd and recommitting to its core mineral exploration projects.

PainChek Limited has secured a pivotal reseller and integration deal with Eldermark Software, positioning its AI-driven pain assessment app for a major US market rollout pending FDA approval.

Optiscan Imaging Ltd has reached a pivotal milestone with the completion of its cloud-based telepathology software MVP, enabling secure, real-time remote collaboration for digital pathology.